Oramed Pharmaceuticals Inc. (FRA:OJU1)

Oramed Pharmaceuticals Statistics

Total Valuation

FRA:OJU1 has a market cap or net worth of EUR 117.37 million. The enterprise value is 1.50 million.

Market Cap	117.37M
Enterprise Value	1.50M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	39.80M
Shares Outstanding	n/a
Shares Change (YoY)	+3.29%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	15.49%
Owned by Institutions (%)	10.76%
Float	30.47M

Valuation Ratios

The trailing PE ratio is 3.14.

PE Ratio	3.14
Forward PE	n/a
PS Ratio	68.85
PB Ratio	0.68
P/TBV Ratio	0.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.04
EV / Sales	0.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.17

Financial Position

The company has a current ratio of 22.24, with a Debt / Equity ratio of 0.00.

Current Ratio	22.24
Quick Ratio	22.08
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 24.48% and return on invested capital (ROIC) is -4.53%.

Return on Equity (ROE)	24.48%
Return on Assets (ROA)	-4.22%
Return on Invested Capital (ROIC)	-4.53%
Return on Capital Employed (ROCE)	-6.07%
Revenue Per Employee	426,150
Profits Per Employee	9.34M
Employee Count	4
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:OJU1 has paid 10.17 million in taxes.

Income Tax	10.17M
Effective Tax Rate	21.41%

Stock Price Statistics

The stock price has increased by +18.89% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+18.89%
50-Day Moving Average	2.29
200-Day Moving Average	2.01
Relative Strength Index (RSI)	74.68
Average Volume (20 Days)	984

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.67

Income Statement

In the last 12 months, FRA:OJU1 had revenue of EUR 1.70 million and earned 37.38 million in profits. Earnings per share was 0.88.

Revenue	1.70M
Gross Profit	11,080
Operating Income	-11.09M
Pretax Income	47.51M
Net Income	37.38M
EBITDA	-10.99M
EBIT	-11.09M
Earnings Per Share (EPS)	0.88

Balance Sheet

The company has 114.79 million in cash and 732,978 in debt, with a net cash position of 114.06 million.

Cash & Cash Equivalents	114.79M
Total Debt	732,978
Net Cash	114.06M
Net Cash Per Share	n/a
Equity (Book Value)	172.45M
Book Value Per Share	4.24
Working Capital	110.80M

Cash Flow

In the last 12 months, operating cash flow was -9.03 million and capital expenditures -15,341, giving a free cash flow of -9.04 million.

Operating Cash Flow	-9.03M
Capital Expenditures	-15,341
Free Cash Flow	-9.04M
FCF Per Share	n/a

Margins

Gross margin is 0.65%, with operating and profit margins of -650.55% and 2,192.60%.

Gross Margin	0.65%
Operating Margin	-650.55%
Pretax Margin	2,787.20%
Profit Margin	2,192.60%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:OJU1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.29%
Shareholder Yield	-3.29%
Earnings Yield	31.84%
FCF Yield	-7.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 23, 2013. It was a reverse split with a ratio of 0.0833333333.

Last Split Date	Jan 23, 2013
Split Type	Reverse
Split Ratio	0.0833333333

Scores

FRA:OJU1 has an Altman Z-Score of 2.8 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.8
Piotroski F-Score	1